Copyright
©The Author(s) 2020.
World J Gastroenterol. May 7, 2020; 26(17): 2064-2081
Published online May 7, 2020. doi: 10.3748/wjg.v26.i17.2064
Published online May 7, 2020. doi: 10.3748/wjg.v26.i17.2064
Table 2 Aberrant crypt foci in different groups
| Group | No. of rat | ACF | |||||
| Small intestine | P value | Colorectum | P value | ||||
| 1 | 10 | 0 | - | 0 | - | ||
| 2 | 10 | 5.0 ± 2.0 | - | 2.8 ± 0.9 | - | ||
| 3 | 18 | 4.9 ± 2.8 | 0.93 | 1.8 ± 1.0 | 0.03 | ||
| 4 | 19 | 3.9 ± 1.5 | 0.23 | 1.6 ± 0.5 | 0.01 | ||
| 5 | 20 | 3.9 ± 1.8 | 0.25 | 1.1 ± 0.3 | < 0.01 | ||
- Citation: Wang Y, Jin HY, Fang MZ, Wang XF, Chen H, Huang SL, Kong DS, Li M, Zhang X, Sun Y, Wang SM. Epigallocatechin gallate inhibits dimethylhydrazine-induced colorectal cancer in rats. World J Gastroenterol 2020; 26(17): 2064-2081
- URL: https://www.wjgnet.com/1007-9327/full/v26/i17/2064.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i17.2064